Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
54
FNB Quote, Financials, Valuation and Earnings
Last price:
$13.49
Seasonality move
:
-1.75%
Day range:
$13.46 - $13.88
52-week range:
$10.88 - $17.70
Dividend yield:
3.52%
P/E ratio:
10.83x
P/S ratio:
3.10x
P/B ratio:
0.76x
Volume:
1.6M
Avg. volume:
3.4M
1-year change:
-1.02%
Market cap:
$4.9B
Revenue:
$1.6B
EPS (TTM):
$1.26
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.4B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | 1.82% | 0.32% | 16.65% | 8.87% | 1.59% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $439M | $450M | $462M | $540M | $566M | |
| Other Inc / (Exp) | $39M | $37M | $35M | -$40M | -$10M | |
| Operating Expenses | $435M | $460M | $462M | $540M | $566M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $343M | $503M | $553M | $584M | $555M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $57M | $98M | $114M | $99M | $90M | |
| Net Income to Company | $286M | $405M | $439M | $485M | $465M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $286M | $405M | $439M | $485M | $465M | |
| Basic EPS (Cont. Ops) | $0.86 | $1.24 | $1.23 | $1.32 | $1.27 | |
| Diluted EPS (Cont. Ops) | $0.85 | $1.23 | $1.22 | $1.31 | $1.27 | |
| Weighted Average Basic Share | $323.4M | $319.8M | $350M | $360.7M | $361.4M | |
| Weighted Average Diluted Share | $325.5M | $323.5M | $354.1M | $362.9M | $362.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $551M | $601M | $718M | $1.2B | $1.5B | |
| Revenue (Reported) | $1.2B | $1.2B | $1.4B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $551M | $601M | $718M | $1.2B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $306M | $312M | $416M | $407M | $411.6M | |
| Revenue Growth (YoY) | 1.66% | 1.96% | 33.33% | -2.16% | 1.13% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $115M | $120M | $131M | $147M | $148.2M | |
| Other Inc / (Exp) | $8M | $7M | $7M | $6M | $5.3M | |
| Operating Expenses | $118M | $94M | $134M | $151M | $152.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $115M | $67M | $182M | $156M | $147.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22M | $14M | $35M | $34M | $30.8M | |
| Net Income to Company | $93M | $53M | $147M | $122M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $93M | $53M | $147M | $122M | $116.5M | |
| Basic EPS (Cont. Ops) | $0.28 | $0.15 | $0.40 | $0.32 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.15 | $0.40 | $0.32 | $0.32 | |
| Weighted Average Basic Share | $321M | $344.4M | $360.9M | $361.2M | $364.1M | |
| Weighted Average Diluted Share | $324.7M | $348.9M | $364.9M | $362.6M | $364.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $143M | $87M | $289M | $380M | $382.9M | |
| Revenue (Reported) | $306M | $312M | $416M | $407M | $411.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $143M | $87M | $289M | $380M | $382.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.5B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $444M | $455M | $473M | $556M | $567.2M | |
| Other Inc / (Exp) | $36M | $36M | $35M | -$41M | -$10.7M | |
| Operating Expenses | $440M | $436M | $479M | $570M | $580.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $400M | $455M | $668M | $558M | $546.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $68M | $90M | $135M | $98M | $86.8M | |
| Net Income to Company | $332M | $365M | $533M | $460M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $332M | $365M | $533M | $460M | $459.5M | |
| Basic EPS (Cont. Ops) | $1.00 | $1.10 | $1.48 | $1.24 | $1.26 | |
| Diluted EPS (Cont. Ops) | $1.00 | $1.10 | $1.46 | $1.24 | $1.26 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $562M | $545M | $920M | $1.3B | $1.5B | |
| Revenue (Reported) | $1.2B | $1.2B | $1.5B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $562M | $545M | $920M | $1.3B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $306M | $312M | $416M | $407M | $411.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $115M | $120M | $131M | $147M | $148.2M | |
| Other Inc / (Exp) | $8M | $7M | $7M | $6M | $5.3M | |
| Operating Expenses | $118M | $94M | $134M | $151M | $152.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $115M | $67M | $182M | $156M | $147.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22M | $14M | $35M | $34M | $30.8M | |
| Net Income to Company | $93M | $53M | $147M | $122M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $93M | $53M | $147M | $122M | $116.5M | |
| Basic EPS (Cont. Ops) | $0.28 | $0.15 | $0.40 | $0.32 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.15 | $0.40 | $0.32 | $0.32 | |
| Weighted Average Basic Share | $321M | $344.4M | $360.9M | $361.2M | $364.1M | |
| Weighted Average Diluted Share | $324.7M | $348.9M | $364.9M | $362.6M | $364.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $143M | $87M | $289M | $380M | $382.9M | |
| Revenue (Reported) | $306M | $312M | $416M | $407M | $411.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $143M | $87M | $289M | $380M | $382.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Short Term Investments | $3.5B | $3.4B | $3.3B | $3.3B | $3B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $5.3B | $7.4B | $5.5B | $5.4B | $6.1B | |
| Property Plant And Equipment | $332M | $345M | $432M | $461M | $536M | |
| Long-Term Investments | $6.3B | $6.9B | $7.4B | $7.2B | $7.4B | |
| Goodwill | $2.3B | $2.3B | $2.5B | $2.5B | $2.5B | |
| Other Intangibles | $54M | $42M | $89M | $69M | $51M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $37.4B | $39.5B | $43.7B | $46.2B | $48.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.3B | $1B | $930M | $1.9B | $585M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $1.4B | $1.2B | $2.4B | $1.1B | |
| Long-Term Debt | $1.2B | $812M | $1.2B | $2.1B | $3.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $32.4B | $34.4B | $38.1B | $40.1B | $42.3B | |
| Common Stock | $110M | $110M | $111M | $111M | $4M | |
| Other Common Equity Adj | -$39M | -$62M | -$357M | -$235M | -$169M | |
| Common Equity | $4.9B | $5B | $5.5B | $5.9B | $6.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5B | $5.2B | $5.7B | $6.1B | $6.3B | |
| Total Liabilities and Equity | $37.4B | $39.5B | $43.7B | $46.2B | $48.6B | |
| Cash and Short Terms | $4.8B | $6.9B | $4.9B | $4.8B | $5.4B | |
| Total Debt | $2.5B | $1.8B | $2.1B | $4B | $3.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.7B | $3.9B | $1.7B | $1.5B | $2.4B | |
| Short Term Investments | $3.2B | $3.4B | $3.2B | $3.2B | $3.5B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6.3B | $7.8B | $5.5B | $5.3B | $6.7B | |
| Property Plant And Equipment | $330M | $394M | $452M | $474M | $539M | |
| Long-Term Investments | $6.2B | $7B | $7.3B | $7.1B | $7.5B | |
| Goodwill | $2.3B | $2.4B | $2.5B | $2.5B | $2.5B | |
| Other Intangibles | $51M | $59M | $84M | $65M | $48M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $38.5B | $42B | $44.1B | $45.9B | $49B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.1B | $930M | $1.6B | $1.4B | $2B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.6B | $1.3B | $2B | $2B | $2B | |
| Long-Term Debt | $1.2B | $845M | $1.4B | $2.2B | $2.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33.5B | $36.6B | $38.4B | $39.9B | $42.6B | |
| Common Stock | $110M | $111M | $111M | $4M | $4M | |
| Other Common Equity Adj | -$51M | -$202M | -$315M | -$250M | -$121M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -$111M | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5B | $5.4B | $5.8B | $6B | $6.4B | |
| Total Liabilities and Equity | $38.5B | $42B | $44.1B | $45.9B | $49B | |
| Cash and Short Terms | $5.8B | $7.3B | $4.9B | $4.7B | $5.9B | |
| Total Debt | $2.3B | $1.8B | $3B | $3.7B | $4.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $286M | $405M | $439M | $485M | $465M | |
| Depreciation & Amoritzation | -$3M | $10M | $73M | $78M | $67M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $19M | $14M | -$42M | -$34M | -$4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $113M | $530M | $1.2B | $423M | $642M | |
| Capital Expenditures | $41M | $58M | $95M | $88M | $139M | |
| Cash Acquisitions | -- | -- | $188M | -- | -- | |
| Cash From Investing | -$1.8B | -$153M | -$3.1B | -$2.3B | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$165M | -$164M | -$179M | -$182M | -$177M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $328M | $25M | $381M | $1.2B | $1.4B | |
| Long-Term Debt Repaid | -$574M | -$438M | -$231M | -$352M | -$341M | |
| Repurchase of Common Stock | -$38M | -$43M | -$43M | -$36M | -$114M | |
| Other Financing Activities | $17M | $16M | $11M | $8M | $12M | |
| Cash From Financing | $2.5B | $1.7B | $18M | $1.7B | $1.9B | |
| Beginning Cash (CF) | $599M | $1.4B | $3.5B | $1.7B | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $784M | $2.1B | -$1.8B | -$98M | $843M | |
| Ending Cash (CF) | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Levered Free Cash Flow | $72M | $472M | $1.1B | $335M | $503M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $72M | $99M | $139M | $51M | $110M | |
| Depreciation & Amoritzation | -$8M | $11M | $19M | $17M | $18M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $1M | -- | -$23M | -$2M | $2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $194M | $146M | $177M | -$20M | $326M | |
| Capital Expenditures | $8M | $15M | $17M | $17M | $48M | |
| Cash Acquisitions | -- | -- | $113M | -- | -- | |
| Cash From Investing | $452M | -$777M | -$642M | -$537M | -$470M | |
| Dividends Paid (Ex Special Dividend) | -$41M | -$41M | -$44M | -$46M | -$44M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $6M | $7M | $14M | $4M | $502M | |
| Long-Term Debt Repaid | -$308M | -$211M | -$8M | -$1M | -$6M | |
| Repurchase of Common Stock | -$13M | -- | -- | $1M | -- | |
| Other Financing Activities | $3M | $4M | $4M | $3M | $2M | |
| Cash From Financing | -$163M | $14M | -$137M | $496M | $485M | |
| Beginning Cash (CF) | $900M | $4.1B | $2.3B | $1.6B | $2.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $483M | -$617M | -$602M | -$61M | $341M | |
| Ending Cash (CF) | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Levered Free Cash Flow | $186M | $131M | $160M | -$37M | $278M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $332M | $365M | $533M | $460M | -- | |
| Depreciation & Amoritzation | -$6M | $24M | $79M | $71M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1M | $15M | -$48M | -$45M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $533M | $673M | $879M | $649M | -- | |
| Capital Expenditures | $41M | $77M | $101M | $84M | $110M | |
| Cash Acquisitions | -- | $75M | $113M | -- | -- | |
| Cash From Investing | -$1.5B | -$123M | -$3.4B | -$1.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -$165M | -$168M | -$180M | -$182M | -$131M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $25M | $24M | $890M | $879M | -- | |
| Long-Term Debt Repaid | -$566M | -$637M | -$331M | -$57M | -- | |
| Repurchase of Common Stock | -$49M | -$37M | -$25M | -$135M | -- | |
| Other Financing Activities | $20M | $13M | $7M | $10M | -- | |
| Cash From Financing | $3.1B | $639M | $413M | $983M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1B | $1.2B | -$2.1B | -$236M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $492M | $596M | $778M | $565M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $405M | $439M | $485M | $465M | -- | |
| Depreciation & Amoritzation | $10M | $73M | $78M | $67M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $14M | -$42M | -$34M | -$4M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $530M | $1.2B | $423M | $642M | -- | |
| Capital Expenditures | $58M | $95M | $88M | $139M | -- | |
| Cash Acquisitions | -- | $188M | -- | -- | -- | |
| Cash From Investing | -$153M | -$3.1B | -$2.3B | -$1.7B | -- | |
| Dividends Paid (Ex Special Dividend) | -$164M | -$179M | -$182M | -$177M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $25M | $381M | $1.2B | $1.4B | -- | |
| Long-Term Debt Repaid | -$438M | -$231M | -$352M | -$341M | -- | |
| Repurchase of Common Stock | -$43M | -$43M | -$36M | -$114M | -- | |
| Other Financing Activities | $16M | $11M | $8M | $12M | -- | |
| Cash From Financing | $1.7B | $18M | $1.7B | $1.9B | -- | |
| Beginning Cash (CF) | $11.1B | $11.7B | $6.7B | $7B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1B | -$1.8B | -$98M | $843M | -- | |
| Ending Cash (CF) | $13.2B | $9.8B | $6.6B | $7.9B | -- | |
| Levered Free Cash Flow | $472M | $1.1B | $335M | $503M | -- | |
Get FNB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FNB
Sector
P/E ratio
10.83x
11.37x
PEG ratio
6.72x
0.38x
P/B ratio
0.76x
1.04x
Price / LTM sales
3.10x
2.45x
Growth Metrics
FNB
Sector
Revenue growth
1.13%
5.74%
Earnings growth
--
6.25%
Revenue (5-year growth)
5.68%
5.15%
Earnings forecast
$0.30
$0.57
Profitability
FNB
Sector
Profitability FY 2025
--
$150.9M
Return on invested capital
4.45%
5.47%
Return on assets
0.96%
0.98%
Return on equity
7.4%
9.38%
Earnings Date
Last Earnings Date
Apr
16
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Jul
16
Balance Sheet
FNB
Sector
Total cash
$5.9B
$523.5M
Short term investments
$3B
$237.7M
Total assets
$48.6B
$4.1B
Long term debt
$4.5B
$299.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
